Citatuzumab bogatox
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Humanized (from mouse) |
Target | TACSTD1 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C3455H5371N921O1060S18 |
Molar mass | 77348.44 g·mol−1 |
(what is this?) (verify) |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors.[2]
References
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ^ Viventia Biotech Inc.: VB6-845 Archived 2010-03-29 at the Wayback Machine
Categories:
- Webarchive template wayback links
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs that are a monoclonal antibody
- All stub articles
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
- Antibody-drug conjugates
- Monoclonal antibodies for tumors